- $5.26bn
- $5.65bn
- €1.19bn
Gerresheimer up as guidance confirmation reassures, analysts say
Brief: Stevanato Group SpA Appoints Franco Stevana to CEO
Vials maker Schott Pharma slides on 2025 profit warning
Stevanato Group SpA reports results for the quarter ended in March - Earnings Summary
Brief: Stevanato Q1 Net Income EUR 18.8 Million Vs. IBES Estimate EUR 29.4 Million
Stevanato Group SpA expected to post earnings of 11 cents a share - Earnings Preview
Stifel resumes Gerresheimer with 'buy' on strong GLP-1 exposure
U.S. STOCKS ON THE MOVE-Reddit, Alphabet, Tesla
U.S. STOCKS ON THE MOVE-Hookipa Pharma, Foot Locker, Baidu
Stevanato slips as co, founding family sell shares in upsized equity offering
Brief: Stevanato Group Prices Underwritten Public Offering At $26 Per Share
Brief: Stevanato Group Launches Underwritten Public Offering Of Aggregate Of $300 Mln Of Ordinary Shares
Brief: Stevanato Group SPA Files For Mixed Shelf Size Not Disclosed-SEC Filing
Stevanato Group SpA reports results for the quarter ended in December - Earnings Summary
Brief: Stevanato Q4 Net Income EUR 45.2 Million
Factbox: How Novo Nordisk makes its weight-loss drug Wegovy
Stevanato Group SpA reports results for the quarter ended in September - Earnings Summary
Brief: Stevanato Q3 Net Income EUR 37.9 Million
Stevanato Group SpA expected to post earnings of 15 cents a share - Earnings Preview